From the Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine/Riley Hospital for Children, Indianapolis, IN.
the Department of Pediatrics, Indiana University School of Medicine/Riley Hospital for Children, Indianapolis, IN.
J Pediatr Gastroenterol Nutr. 2022 Oct 1;75(4):514-520. doi: 10.1097/MPG.0000000000003566. Epub 2022 Jul 18.
Pediatric gastroenterologists are often consulted to perform diagnostic and therapeutic endoscopy in infants with gastrointestinal bleeding (GIB). The value of endoscopy and risk of complications in this population are not well characterized. We aimed to describe findings and outcomes of infants with GIB who undergo endoscopy.
Retrospective, single-center, cohort study of hospitalized infants ≤12 months who underwent esophagogastroduodenoscopy (EGD) and/or colonoscopy/flexible sigmoidoscopy (COL) for GIB. Current procedural technology codes, international classification of diseases codes, and quality control logs identified infants.
Fifty-six infants were identified from 2008 to 2019 (51.8% female; mean age 161.6 days). Seven endoscopies identified sources of GIB: gastric ulcers, a duodenal ulcer, gastric angiodysplasia, esophageal varices, and an anastomotic ulcer. Three infants underwent therapeutic interventions of banding/sclerotherapy of esophageal varices and triamcinolone injection of an anastomotic ulcer. Six infants underwent abdominal surgery for GIB or suspected intestinal perforation after endoscopy, where a gastric perforation, jejunal perforation at an anastomotic stricture, necrotizing enterocolitis totalis with perforation, Meckel's diverticulum, and a duodenal ulcer were identified. No source of bleeding was identified surgically in 1 infant with GIB. Respiratory failure, use of vasopressors or octreotide, administration of blood products, and high blood urea nitrogen were associated with increased likelihood of requiring surgery ( P < 0.05 for all).
There was limited utility to performing endoscopy in infants ≤12 months old with clinical GIB. Endoscopy in these sick infants carries risk, and 3 infants in this series presented with a gastrointestinal (GI) perforation shortly after the procedure. These limitations and risks should influence clinical decision-making regarding endoscopy in infants with GIB.
儿科胃肠病学家经常被要求对患有胃肠道出血 (GIB) 的婴儿进行诊断和治疗性内镜检查。该人群内镜检查的价值和并发症风险尚未得到很好的描述。我们旨在描述接受内镜检查的患有 GIB 的婴儿的检查结果和结局。
这是一项回顾性、单中心队列研究,纳入了 2008 年至 2019 年期间因 GIB 接受食管胃十二指肠镜检查 (EGD) 和/或结肠镜检查/乙状结肠镜检查 (COL) 的住院婴儿。使用当前的程序技术代码、国际疾病分类代码和质量控制日志来识别婴儿。
2008 年至 2019 年期间,共确定了 56 名婴儿(51.8%为女性;平均年龄 161.6 天)。7 次内镜检查确定了 GIB 的来源:胃溃疡、十二指肠溃疡、胃血管发育不良、食管静脉曲张和吻合口溃疡。3 名婴儿接受了食管静脉曲张套扎/硬化治疗和吻合口溃疡曲安奈德注射的治疗干预。6 名婴儿因 GIB 或内镜检查后疑似肠穿孔而行腹部手术,其中 1 名婴儿的胃穿孔、吻合口狭窄处的空肠穿孔、全坏死性小肠结肠炎伴穿孔、 Meckel 憩室和十二指肠溃疡被发现。1 名患有 GIB 的婴儿在手术中未发现出血源。呼吸衰竭、使用血管加压素或奥曲肽、输血和高血尿素氮与更有可能需要手术的可能性相关(所有 P < 0.05)。
对患有临床 GIB 的≤12 个月大的婴儿进行内镜检查的作用有限。这些患病婴儿的内镜检查存在风险,并且该系列中有 3 名婴儿在手术后不久出现了胃肠道 (GI) 穿孔。这些局限性和风险应影响临床决策,即决定是否对患有 GIB 的婴儿进行内镜检查。